DENMARK – The Danish biological solutions company, Novozymes is launching Saphera Fiber, a new lactase enzyme which enables manufactures to…
Read MoreTag: Novozymes
Green Plains and Novozymes partner in production of protein ingredients
USA – Diversified commodity-processing company, Green Plains has entered into an exclusive partnership with Danish company, Novozymes for biological solutions…
Read MoreNovozymes unveils new enzymatic toolbox for development of oat drinks
DENMARK – Novozymes has developed a new toolbox to help guide producers on expanding their businesses into the oat drinks…
Read MoreNovozymes makes organizational changes to deliver on growth strategy
DENMARK – The biological solutions company, Novozymes has announced some organizational changes that will include loss of upto 330 jobs…
Read MoreCourt rules in favor of DuPont in Danisco patent ownership case
DENMARK – The Danish Maritime and Commercial Court has confirmed DuPont’s ownership of two amylase patent applications in Novozyme’s entitlement…
Read MoreDenmark based biotech company Novozymes opens regional office in Kenya
KENYA – Novozymes, a Denmark based global biotechnology company, has opened a regional office in Nairobi, Kenya as it seeks…
Read MoreNovozymes invites collaboration on global challenges
DENMARK – Novozymes, the world leader in biological solutions, has launched HelloScience, an online network where innovators, start-ups, companies and…
Read MoreTop court rules in favor of Novozymes in patent dispute with Chinese firms
CHINA – The Supreme People’s Court of China, the country’s highest court, has ruled against two local firms in a patent infringement case brought by enzyme maker, Novozymes, in what the company calls an ‘important step towards protecting biotech innovations.’
Read MoreTop court rules in favor of Novozymes in patent dispute with Chinese firms
CHINA – The Supreme People’s Court of China, the country’s highest court, has ruled against two local firms in a patent infringement case brought by enzyme maker, Novozymes, in what the company calls an ‘important step towards protecting biotech innovations.’
Read More